Evidence map›Paper›PMID 39874182›Full record

ArticleeLife2025

Anastasiia Lozovska, Ana Casaca, Ana Novoa, Ying-Yi Kuo, Arnon D Jurberg, Gabriel G Martins, Anna-Katerina Hadjantonakis, Moises Mallo

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. The Link Between TGF-β Signaling and Chromatin Dynamics Takes an Unexpected Path.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  2. eLife · 2025
    Article
  3. Article
4 · The record

Corrections and comments

  • Update of
    2024
5 · Who and what money

Authors and funding

8 authors.

Anastasiia LozovskaInstituto Gulbenkian de Ciência, Rua da Quinta Grande, Oeiras, Portugal.ORCID https://orcid.org/0000-0002-9842-6450
Ana CasacaInstituto Gulbenkian de Ciência, Rua da Quinta Grande, Oeiras, Portugal.
Ana NovoaInstituto Gulbenkian de Ciência, Rua da Quinta Grande, Oeiras, Portugal.
Ying-Yi KuoDevelopmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, United States.ORCID https://orcid.org/0000-0002-1962-5559
Arnon D JurbergInstituto Gulbenkian de Ciência, Rua da Quinta Grande, Oeiras, Portugal.
Gabriel G MartinsInstituto Gulbenkian de Ciência, Rua da Quinta Grande, Oeiras, Portugal.
Anna-Katerina HadjantonakisDevelopmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, United States.
Moises MalloInstituto Gulbenkian de Ciência, Rua da Quinta Grande, Oeiras, Portugal.ORCID https://orcid.org/0000-0002-9744-0912

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
ISOLATION OF NOVEL MUTATIONS AFFECTING THE MOUSE EMBRYOR01HD035455 · NICHD · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI HADJANTONAKIS, ANNA-KATERINA, HUANGFU, DANWEI · 1998 to 2022
$7.1M
Mechanisms driving cell fate specification and morphogenesis in the blastocystR01HD094868 · NICHD · SLOAN-KETTERING INST CAN RESEARCH · PI ANNA-KATERINA HADJANTONAKIS · 2018 to 2026
$4.2M
The gut endoderm: origin, formation and fateR01DK127821 · NIDDK · SLOAN-KETTERING INST CAN RESEARCH · PI ANNA-KATERINA HADJANTONAKIS · 2021 to 2026
$3.4M
Fundacao para a Ciencia e a Technologia DOI: 10.54499/2022.01629.PTDCFundacao para a Ciencia e a Tecnologia PD/BD/128437/2017NCI NIH HHS P30 CA008748NICHD NIH HHS R01 HD035455NICHD NIH HHS R01 HD094868NIDDK NIH HHS R01 DK127821NIH HHS P30CA008748NIH HHS R01DK127821NIH HHS R01HD035455NIH HHS R01HD094868
6 · The paper itself

Abstract

During the trunk to tail transition the mammalian embryo builds the outlets for the intestinal and urogenital tracts, lays down the primordia for the hindlimb and external genitalia, and switches from the epiblast/primitive streak (PS) to the tail bud as the driver of axial extension. Genetic and molecular data indicate that Tgfbr1 is a key regulator of the trunk to tail transition. Tgfbr1 has been shown to control the switch of the neuromesodermal competent cells from the epiblast to the chordoneural hinge to generate the tail bud. We now show that in mouse embryos Tgfbr1 signaling also controls the remodeling of the lateral plate mesoderm (LPM) and of the embryonic endoderm associated with the trunk to tail transition. In the absence of Tgfbr1, the two LPM layers do not converge at the end of the trunk, extending instead as separate layers until the caudal embryonic extremity, and failing to activate markers of primordia for the hindlimb and external genitalia. The vascular remodeling involving the dorsal aorta and the umbilical artery leading to the connection between embryonic and extraembryonic circulation was also affected in the Tgfbr1 mutant embryos. Similar alterations in the LPM and vascular system were also observed in Isl1 null mutants, indicating that this factor acts in the regulatory cascade downstream of Tgfbr1 in LPM-derived tissues. In addition, in the absence of Tgfbr1 the embryonic endoderm fails to expand to form the endodermal cloaca and to extend posteriorly to generate the tail gut. We present evidence suggesting that the remodeling activity of Tgfbr1 in the LPM and endoderm results from the control of the posterior PS fate after its regression during the trunk to tail transition. Our data, together with previously reported observations, place Tgfbr1 at the top of the regulatory processes controlling the trunk to tail transition.

Indexed as

EndodermMesodermProtein Serine-Threonine KinasesReceptor, Transforming Growth Factor-beta Type ITailAnimalsEmbryo, MammalianGene Expression Regulation, DevelopmentalMiceSignal TransductionProtein Serine-Threonine KinasesReceptor, Transforming Growth Factor-beta Type ITgfbr1 protein, mousedevelopmental biologyendodermIsl1lateral plate mesodermmouseTgfbr1trunk to tail transitionvascular remodeling

Identifiers

PMID39874182
PMCPMC11774515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.